EFDA Officials Meet with Brazilian Pharmaceutical Investors
ADDIS ABABA, ETHIOPIA — The Ethiopian Food and Drug Authority (EFDA) has held discussions with a Brazilian investment delegation to explore opportunities in the country’s pharmaceutical and medical supplies manufacturing sector.
On August 25, 2025, Mr. Seyoum Wolde, Deputy Director-General of the EFDA’s Pharmaceuticals Sector, welcomed the delegation from Bio Cure Pharma Biotechnology. During the meeting, he provided the investors with a detailed explanation of Ethiopia’s regulatory framework, laws, and the extensive investment opportunities available.
Mr. Seyoum highlighted Ethiopia’s potential and the favorable environment created for investors in the pharmaceutical and food sectors, including the establishment of dedicated industrial parks. He emphasized that the EFDA, as the regulatory body, is committed to supporting all investors from the initial stages of their projects.
The delegation was also briefed on the overall regulatory processes and quality and safety assurance procedures in place. The officials extended an invitation to the Brazilian company to invest in Ethiopia and contribute to the country’s growing healthcare manufacturing industry
